Average Co-Inventor Count = 7.29
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Centrexion Therapeutics Corporation (9 from 36 patents)
2. Boehringer Ingelheim International Gmbh (7 from 1,536 patents)
16 patents:
1. 12209094 - CCR2 receptor antagonists and uses thereof
2. 11731981 - CCR2 receptor antagonists and uses thereof
3. 11046706 - CCR2 receptor antagonists and uses thereof
4. 10675268 - Somatostatin receptor subtype 4 (SSTR4) agonists
5. 10577336 - Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
6. 10196402 - CCR2 receptor antagonists and uses thereof
7. 10183940 - Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists
8. 10166214 - Somatostatin receptor subtype 4 (SSTR4) agonists
9. 10071974 - Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists
10. 9789082 - Somatostatin receptor subtype 4 (SSTR4) agonists
11. 9670222 - CCR2 receptor antagonists and uses thereof
12. 9371282 - Somatostatin receptor subtype 4 (SSTR4) agonists
13. 9012489 - Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
14. 8946218 - CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
15. 8877745 - CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments